Skip to main content

Coda Genomics, Genencor Sign Screening Agreement

NEW YORK (GenomeWeb News) – Synthetic biology company Coda Genomics said yesterday that it has signed a collaborative agreement with biotechnology company Genencor, a division of Danish firm Danisco.
 
Under the agreement, Coda will use its proprietary approach to develop synthetic gene and protein libraries, which will be screened for use in future research programs by Genencor. Financial terms of the agreement were not disclosed.
 
Genencor develops and markets enzyme and bio-based products for industrial biotechnology, while Coda applies synthetic technologies to create new genes, proteins, and organisms for bioindustrial and life sciences applications.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.